Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-14-001020
Filing Date
2014-04-02
Accepted
2014-04-02 17:28:14
Documents
5
Period of Report
2014-05-22
Effectiveness Date
2014-04-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1400573_def14a.htm DEF 14A 347373
2 GRAPHIC pc_1.jpg GRAPHIC 961102
3 GRAPHIC pc_2.jpg GRAPHIC 817482
4 GRAPHIC pc_3.jpg GRAPHIC 851321
5 GRAPHIC pc_4.jpg GRAPHIC 703587
  Complete submission text file 0001571049-14-001020.txt   4941880
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 14739404
SIC: 2834 Pharmaceutical Preparations